Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 12, 2013, Pages 4107-4125

  Roman, Markus ^a   Ström, Lena ^a   Tell, Helena ^a   Josefsson, Martin ^b  

^a DEPARTMENT OF FORENSIC GENETICS AND FORENSIC TOXICOLOGY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Blood; Liquid chromatography; Liquid chromatography time of flight mass spectrometry; Mass spectrometry; Postmortem; Time of flight

Indexed keywords

ELECTROSPRAY IONIZATION; GAS CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; INDUCTIVELY COUPLED PLASMA; IONIZATION OF GASES; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLITES; NEGATIVE IONS; PRODUCT DEVELOPMENT; SCREENING;

ACCURATE MASS MEASUREMENTS; COEFFICIENT OF VARIATION; LIQUID CHROMATOGRAPHY TIME-OF-FLIGHT MASS SPECTROMETRIES; MASS SPECTROMETRY ANALYSIS; NEGATIVE ELECTROSPRAY IONIZATIONS; NITROGEN-PHOSPHORUS DETECTION; POSTMORTEM; TIME OF FLIGHT;

BLOOD;

DRUG;

ANIMAL; ARTICLE; BLOOD; CATTLE; FORENSIC TOXICOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; VALIDATION STUDY;

ANIMALS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FORENSIC TOXICOLOGY; HUMANS; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

EID: 84886834130     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6798-0     Document Type: Article

References (29)

1. Maurer HH (2004) Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med 42:1310-1324
2. Drummer OH (2007) Requirements for bioanalytical procedures in postmortem toxicology. Anal Bioanal Chem 388:1495-1503
3. Peters FT (2011) Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 44:54-65
4. Skopp G (2010) Postmortem toxicology. Forensic Sci Med Pathol 6:314-325
5. Maurer HH (2010) Perspectives of liquid chromatography coupled to low-and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit 32:324-327
6. Ojanperä I, Kolmonen M, Pelander A (2012) Current use of highresolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal Bioanal Chem 403:1203-1220
7. Ojanperä I, Pelander A, Laks S, Gergov M, Vuori E,Witt M(2005) Application of accurate mass measurement to urine drug screening. J Anal Toxicol 29:34-40
8. Ojanperä S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanperä I (2006) Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 20:1161-1167
9. Lee HK, Ho CS, Iu YPH, Lai PSJ, Shek CC, Lo Y-C, Bendstrup Klinke H, Wood M (2009) Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Anal Chim Acta 649:80-90
10. Tyrkkö E, Pelander A, Ojanperä I (2010) Differentiation of structural isomers in a target drug database by LC/Q-TOFMS using fragmentation prediction. Drug Test Anal 2:259-270
11. Bijlsma L, Sancho JV, Hernández F, Niessen WM (2011) Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MS(E) accurate-mass spectra. J Mass Spectrom 46:865-875
12. Broecker S, Herre S, Wüst B, Zweigenbaum J, Pragst F (2011) Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 400:101-117
13. De Castro A, Gergov M, Östman P, Ojanperä I, Pelander A (2012) Combined drug screening and confirmation by liquid chromatography time-of-flight mass spectrometry with reverse database search. Anal Bioanal Chem 403:1265-1278
14. Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Ojanperä I (2009) Generic sample preparation and dual polarity liquid chromatography-time-of- flight mass spectrometry for highthroughput screening in doping analysis. Drug Test Anal 1:250-266
15. Peters RJB, Oosterink JE, Stolker AA, Georgakopoulos C, Nielen MW (2010) Generic sample preparation combined with highresolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories. Anal Bioanal Chem 396:2583-2598
16. Dalsgaard PW, Rasmussen BS, Müller IB, Linnet K (2011) Toxicological screening of basic drugs in whole blood using UPLCTOF-MS. Drug Test Anal 4:313-319
17. Marin SJ, Huges JM, Lawlor BG, Chantry JC, McMillin GA (2012) Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS. J Anal Toxicol 36:477-486
18. Pelander A, Ristimaa J, Rasanen I, Vuori E, Ojanperä I (2008) Screening for basic drugs in hair of drug addicts by liquid chromatography/time- of-flight mass spectrometry. Ther Drug Monit 30:717-724
19. Nielsen MK, Johansen SS, Dalsgaard PW, Linnet K (2010) Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS. Forensic Sci Int 196:85-92
20. Domínguez-Romero JC, García-Reyes JF, Molina-Díaz A (2011) Screening and quantitation of multiclass drugs of abuse and pharmaceuticals in hair by fast liquid chromatography electrospray time-of-flight mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 879:2034-2042
21. Broecker S, Herre S (2011) Pragst F (2011) General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Forensic Sci Int 218:68-81
22. Pelander A, Ristimaa J, Ojanperä I (2010) Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry. J Anal Toxicol 34:312-318
23. Ristimaa J, Gergov M, Pelander A, Halmesmäki E, Ojanperä I (2010) Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-offlight mass spectrometry. Anal Bioanal Chem 398:925-935
24. Careri M, Mangia A (2006) Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems. Anal Bioanal Chem 386:38-45
25. Peters F, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216-224
26. Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in post-mortem femoral blood. J For Sci 42:79-87
27. United Nations Office on Drugs and Crime (2011) Guidelines for the forensic analysis of drugs facilitating sexual assault and other criminal acts (2011) United Nations Office on Drugs and Crime, Vienna. http://www.unodc.org/ documents/scientific/forensic- analys-of-drugs-facilitating-sexual-assault-and- other-criminal- acts.pdf. Accessed 21 Dec 2012
28. Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R (2003) Optimimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography tandem mass spectrometry. J Chromatogr B 785:263-275
29. Chambers E, Wagrowski-Diehl DM, Lu Z, Masseo JR (2007) Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B 852:22-34